Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitors

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (22173020)

This publication has 128 references indexed in Scilit: